Patient Outcome AssessmentOutcome Assessment (Health Care): Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure).Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Injections, Epidural: The injection of drugs, most often analgesics, into the spinal canal without puncturing the dura mater.Research Design: A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.Quality of Life: A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.Outcome and Process Assessment (Health Care): Evaluation procedures that focus on both the outcome or status (OUTCOMES ASSESSMENT) of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process (ASSESSMENT, PROCESS) - what is done for the patient diagnostically and therapeutically.Disability Evaluation: Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits.Sports Medicine: The field of medicine concerned with physical fitness and the diagnosis and treatment of injuries sustained in exercise and sports activities.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Risk Assessment: The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)Reproducibility of Results: The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.Randomized Controlled Trials as Topic: Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Severity of Illness Index: Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.Empirical Research: The study, based on direct observation, use of statistical records, interviews, or experimental methods, of actual practices or the actual impact of practices or policies.Fluoroscopy: Production of an image when x-rays strike a fluorescent screen.Patient Satisfaction: The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial.Activities of Daily Living: The performance of the basic activities of self care, such as dressing, ambulation, or eating.Spinal Stenosis: Narrowing of the spinal canal.Recovery of Function: A partial or complete return to the normal or proper physiologic activity of an organ or part following disease or trauma.United StatesQuestionnaires: Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.Single-Blind Method: A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned.Pain Measurement: Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies.Clinical Trials as Topic: Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.Predictive Value of Tests: In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.Health Status Indicators: The measurement of the health status for a given population using a variety of indices, including morbidity, mortality, and available health resources.Intervertebral Disc Displacement: An INTERVERTEBRAL DISC in which the nucleus pulposus has protruded through surrounding fibrocartilage. This occurs most frequently in the lower lumbar region.Cohort Studies: Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Prognosis: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.Physical Therapy Modalities: Therapeutic modalities frequently used in PHYSICAL THERAPY SPECIALTY by PHYSICAL THERAPISTS or physiotherapists to promote, maintain, or restore the physical and physiological well-being of an individual.Educational Measurement: The assessing of academic or educational achievement. It includes all aspects of testing and test construction.Low Back Pain: Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)Lumbosacral Region: Region of the back including the LUMBAR VERTEBRAE, SACRUM, and nearby structures.Evidence-Based Medicine: An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006)Pregnancy Outcome: Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)Range of Motion, Articular: The distance and direction to which a bone joint can be extended. Range of motion is a function of the condition of the joints, muscles, and connective tissues involved. Joint flexibility can be improved through appropriate MUSCLE STRETCHING EXERCISES.

*  SAVOR-TIMI 53: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients

SAVOR-TIMI 53: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 Study 02 ... Session Title: SAVOR-TIMI 53: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)- ... 16,500 patients with T2DM. Eligible patients with HbA1c ,=6.5% and ,12.0% on any background antidiabetic treatment (except ... The mean age was 65 years, 67% of patients were male, and the median duration of T2DM at randomization was 11.9 years. Database ...

*  Validity of the Manchester Triage System in patients with sepsis presenting at the ED: a first assessment | Emergency Medicine...

Outcome. The primary outcome was the proportion of patients with any sepsis who were categorised in one of the three highest ... Patients with sepsis. Among all 801 patients with sepsis, 564 patients (70.4%) were allocated to 'yellow', 'orange' or 'red', ... Laboratory tests revealed leukocytosis in 13 patients, leucopenia in 9 patients and positive blood culture in 7 patients. ... one patient (3.8%) to category 'green' and no patient was triaged into category 'blue'. Seven patients assigned to 'yellow' had ...

*  Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma - Full Text View -

Median Maximum Score for Patient Reported Outcomes in 2 Blinded Cycles [ Time Frame: Within the first 2 blinded cycles (3-week ... Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma. This study has been completed. ... Patient has an active seizure disorder. Patients with a previous history of seizure disorders will be eligible for the study, ... Patients with metastatic disease to CNS.. *Patient has uncontrolled angina, congestive heart failure (New York Heart ...

*  Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose...

Primary Outcome Measures: *2-year overall survival. Secondary Outcome Measures: *Toxicity assessment. *Assessment of ... 1997). For patient entering Arm B (with N0 stage) confirmation of N1-N2 stage must be obtained from intraoperative or post- ... Patients with clinically measurable lesions will be enrolled in this study. Measurability is determined according to RECIST ... Histologically or cytologically confirmed diagnosis of NSCLC (any subtype). For patients entering Arm B is also allowed to ...

*  Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE...

Health status was assessed with the Medical Outcomes Survey Short Form-36 (SF-36) [34], a widely used patient-reported outcomes ... Part I. Assessment. J Pract Psychiatry Behav. 1997;3:106-110.. *Kane JM. Treatment adherence and long term outcomes. CNS Spectr ... To evaluate effectiveness outcomes in a real-world setting in patients with schizophrenia initiating risperidone long-acting ... Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in ...

*  ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients - Full Text View -

Assessment of hepatic function; Assessment of nutritional efficacy. [ Time Frame: At the end of the study and 6 months after ... Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after ... Patients that received chronic treatment with corticoids in the month preceding admission to ICU. Patients receiving treatment ... Secondary Outcome Measures: *Study mortality at the end of the study and 6 months after discharge from ICU; Hospital stay and/ ...

*  Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells...

Original Primary Outcome Measures ICMJE Not Provided. Change History Complete list of historical versions of study NCT00000883 ... Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells ... Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells ... Patients in ACTG 362 have been exposed to anti-HIV therapy longer than any other large group in the ACTG. These patients appear ...

*  Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy - Full Text View -

Outcome Measures: The primary outcome measure used will be the Adult Myopathy Assessment Tool (AMAT). Secondary outcome ... Primary Outcome Measures: *Adult Myopathy Assessment Tool (AMAT). Secondary Outcome Measures: *To assess the effect of ... The subjects will provide blood work for analysis of hormonal levels and assessment of any potential muscle damage. On the ... To assess the ability of patients to maintain exercise compliance as measured by accelerometer measurements.. *To assess the ... technology&recr=Open&fund=0&rank=4

*  Objective Evaluation of Patients With Palmar Hyperhidrosis Submitted to Two Levels of Sympathectomy: T3 and T4. - Full Text...

Secondary Outcome Measures: *Assessment of quality of life. [ Time Frame: 12 months ]. We evaluated the quality of life before ... These studies have been based on subjective quantification of sweating (assessment of sweating reported by patients) and on the ... We selected 40 patients from February 2007 to May 2009. All participants were randomized into two groups of 20 patients (G3 and ... Objective Evaluation of Patients With Palmar Hyperhidrosis Submitted to Two Levels of Sympathectomy: T3 and T4.. This study has ...

*  BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's...

assessment of efficacy, safety, pharmacokinetics, immunogenicity. [ Time Frame: end of study ]. Secondary Outcome Measures: * ... Patients receive BL22 immunotoxin IV over 30 minutes on days 1, 3, and 5 OR on days 1, 3, 5, 7, 9, and 11. Treatment repeats ... Patients who achieve a complete response (CR) or unconfirmed CR (CRu) receive 2 additional courses beyond CR or CRu for a ... Patients who achieve a complete response (CR) or unconfirmed CR (CRu) receive 2 additional courses beyond CR or CRu for a ...

Time-trade-off: Time-Trade-Off (TTO) is a tool used in health economics to help determine the quality of life of a patient or group. The individual will be presented with a set of directions such as:International Disability and Development Consortium: The International Disability and Development Consortium (IDDC) is a global consortium of disability and development related organisations. The aim of IDDC is to promote inclusive development internationally, with a special focus on promoting human rights for all disabled people living in economically poor communities in lower and middle-income countries.Larry LemakGlobal Risks Report: The Global Risks Report is an annual study published by the World Economic Forum ahead of the Forum’s Annual Meeting in Davos, Switzerland. Based on the work of the Global Risk Network, the report describes changes occurring in the global risks landscape from year to year and identifies the global risks that could play a critical role in the upcoming year.Generalizability theory: Generalizability theory, or G Theory, is a statistical framework for conceptualizing, investigating, and designing reliable observations. It is used to determine the reliability (i.AIP Conference Proceedings: AIP Conference Proceedings is a serial published by the American Institute of Physics since 1970. It publishes the proceedings from various conferences of physics societies.Temporal analysis of products: Temporal Analysis of Products (TAP), (TAP-2), (TAP-3) is an experimental technique for studyingBristol Activities of Daily Living Scale: The Bristol Activities of Daily Living Scale (BADLS) is a 20-item questionnaire designed to measure the ability of someone with dementia to carry out daily activities such as dressing, preparing food and using transport.Spinal stenosis: Spinal stenosis is an abnormal narrowing (stenosis) of the spinal canal that may occur in any of the regions of the spine. This narrowing causes a restriction to the spinal canal, resulting in a neurological deficit.List of Parliamentary constituencies in Kent: The ceremonial county of Kent,Closed-ended question: A closed-ended question is a question format that limits respondents with a list of answer choices from which they must choose to answer the question.Dillman D.Pain scale: A pain scale measures a patient's pain intensity or other features. Pain scales are based on self-report, observational (behavioral), or physiological data.Community-based clinical trial: Community-based clinical trials are clinical trials conducted directly through doctors and clinics rather than academic research facilities. They are designed to be administered through primary care physicians, community health centers and local outpatient facilities.Lumbar disc disease: Lumbar disc disease is the drying out of the spongy interior matrix of an intervertebral disc in the spine. Many physicians and patients use the term lumbar disc disease to encompass several different causes of back pain or sciatica.QRISK: QRISK2 (the most recent version of QRISK) is a prediction algorithm for cardiovascular disease (CVD) that uses traditional risk factors (age, systolic blood pressure, smoking status and ratio of total serum cholesterol to high-density lipoprotein cholesterol) together with body mass index, ethnicity, measures of deprivation, family history, chronic kidney disease, rheumatoid arthritis, atrial fibrillation, diabetes mellitus, and antihypertensive treatment.Select MedicalLow back painList of kanji by stroke count: This Kanji index method groups together the kanji that are written with the same number of strokes. Currently, there are 2,186 individual kanji listed.Bestbets: BestBETS (Best Evidence Topic Reports) is a system designed by emergency physicians at Manchester Royal Infirmary, UK. It was conceived as a way of allowing busy clinicians to solve real clinical problems using published evidence.Non-communicable disease: Non-communicable disease (NCD) is a medical condition or disease that is non-infectious or non-transmissible. NCDs can refer to chronic diseases which last for long periods of time and progress slowly.

(1/93) Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.


(2/93) Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults.


(3/93) Passive cooling during transport of asphyxiated term newborns.


(4/93) What is the significance of perioperative release of macrophage migration inhibitory factor in cardiac surgery?


(5/93) Single- versus multilevel fusion for single-level degenerative spondylolisthesis and multilevel lumbar stenosis: four-year results of the spine patient outcomes research trial.


(6/93) Predictive validity of the Manchester Triage System: evaluation of outcomes of patients admitted to an emergency department.


(7/93) Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm.


(8/93) Predicting asthma outcomes in commercially insured and Medicaid populations?

OBJECTIVES: To assess the predictive ability of the ratio of controller-to-total asthma medication in commercially insured and Medicaid patients. STUDY DESIGN: Retrospective cohort. METHODS: Medical and pharmacy claims were used to identify asthma patients between 2004 and 2006. Ratios were computed during 3-, 6-, and 12-month assessment periods and asthma exacerbations were assessed during a subsequent 12-month follow-up period. Receiver operating characteristic curve analyses and logistic regression were used to select optimal ratio number, assessment time period, and incremental ratio analysis. RESULTS: The ratio significantly predicted future asthma exacerbations. An optimal value of >0.7 was identified in pediatric and adult Medicaid patients with a shorter assessment period in adults (3 months) than in children (6 months). In commercially insured patients, an optimal value of >0.5 during a 6-month assessment period was identified for children and adults. In commercially insured patients, a 0.1-unit increase in the ratio below the 0.5 value resulted in a 72% (odds ratio [OR] 0.28; 95% confidence interval [CI] 0.13-0.57) and 80% (OR 0.20; 95% CI 0.12-0.33) risk reduction among pediatric and adult patients, respectively. Similarly, a 0.1-unit increase in the ratio below the 0.7 optimal value in the Medicaid population resulted in significant risk reduction in the pediatric (OR 0.65; 95% CI 0.43-0.97) but not the adult cohort. CONCLUSIONS: The ratio is a significant predictive risk marker in commercially insured and Medicaid asthma populations. Incremental risk reductions can be realized by unit increases in the ratio up to the identified optimal value.  (+info)


  • Patients with schizophrenia who were initiated on RLAT demonstrated improvements in measures of effectiveness within 3 months, which persisted over 24 months. (
  • The current study should provide validated measures of immune restoration and clinical data to guide prophylaxis decisions for the many patients who are now responding to therapy after years of immune depletion. (
  • OUTCOME MEASURES: North American Spine Society outcome assessment instrument. (
  • Patients with glycated hemoglobin ≥ 7.5 within 6 months were enrolled and completed self-report measures on demographics, health status, and self-care (n = 146). (


  • SAVOR-TIMI 53 is a phase 4, randomized, double-blind, placebo-controlled, trial designed to evaluate the safety and efficacy of saxagliptin during long-term treatment of ~16,500 patients with T2DM. (
  • To evaluate the preliminary efficacy of palifermin in reducing the incidence and severity of oral mucositis (OM) in patients with sarcoma receiving multicycle chemotherapy. (
  • The purpose of this study is to test feasibility, toxicity and efficacy of two different adjuvant treatment schedules in Stage II-IIIa Non-small cell lung cancer patients with positive lymph nodes. (
  • Assessment of nutritional efficacy. (
  • Determine the therapeutic efficacy of this drug in inducing remissions in these patients. (


  • To evaluate effectiveness outcomes in a real-world setting in patients with schizophrenia initiating risperidone long-acting therapy (RLAT). (
  • The objective of the present Post Marketing Surveillance Study (PMS) study is to evaluate safety and effectiveness of tiotropium bromide (Spiriva®) 18 µg once daily in 5,000 patients with COPD of varying severities over 8 weeks. (


  • Conclusions The MTS has some weaknesses regarding priority levels in emergency patients with septic illness. (
  • CONCLUSIONS: In patients with transvenous ventricular leads across the tricuspid valve, echocardiography demonstrates a small, but statistically significant change in TR. (
  • Conclusions- Mild hypothermia with a surface-cooling device in an acute stroke unit is safe and feasible in thrombolyzed, spontaneously breathing patients with stroke, despite the adverse events. (


  • To assess the effect of functional exercise on adverse outcomes as measured by an adverse event questionnaire. (
  • We evaluated the quality of life before and after operation by questionnaire supplied to patients. (
  • After the treatment, the patients were asked to grade the improvement in each item of the same QOL questionnaire. (
  • PURPOSE: This study examined whether the factor structure of the NASS varied in relation to the severity of the back/neck problem and differed from that originally recommended by the developers of the questionnaire, by analyzing data before and after surgery in a large series of patients undergoing lumbar or cervical disc arthroplasty. (
  • Patients will fill up a questionnaire regarding their disease, demographic data, other co-morbidities and medications and risk factors for metabolic syndrome. (


  • Because of the severity of symptoms and the long-term, chronic pattern of schizophrenia, patients often have significant disability with serious physical, social, and economic consequences [ 2 , 3 ]. (


  • The MTD is defined as the dose preceding that at which 2 of 3 or 2 of 6 patients experience dose-limiting toxicity. (


  • This was a 24-month, multicenter, prospective, longitudinal, observational study in patients with schizophrenia who were initiated on RLAT. (
  • After 3 prospective observational studies on mild or moderate hypothermia in patients with acute ischemic stroke, 9 - 11 3 randomized controlled hypothermia trials in stroke have been reported. (

Risk Factors

  • To evaluate the frequency of fatty liver in a cohort of IBD patients and to learn its risk factors. (


  • METHODS: First, an exploratory FA without a priori assumptions and subsequently a confirmatory FA were performed on the 17 items of the NASS-lumbar and 19 items of the NASS-cervical collected at each assessment time point. (
  • METHODS AND RESULTS: A retrospective chart review was conducted at a large children's hospital, yielding 123 patients with initial placement of a transvenous lead across their tricuspid valve that had adequate echocardiographic data for review. (
  • METHODS: A 1-year retrospective records review identified all hot-loaded patients. (
  • Methods- Patients were randomized 1:1 to mild hypothermia (35°C) or to standard stroke unit care within 6 hours of symptom onset. (


  • Clinical condition and nosocomial infection will be monitored daily until the first phase of the study is completed on day 28 or the patient is discharged from the unit. (
  • The currently available data on clinical events in patients receiving potent antiretroviral therapy suggest that an alteration in the presentation of MAC disease may be seen and that rates of MAC disease may be reduced when patients respond to antiretroviral therapy. (
  • These plans present clinical examples of patients with a particular diagnosis and demonstrate plans of care that follow patients through various diagnostic stages and care delivery settings. (
  • Criteria Patients with clinical diagnosis of stable Chronic Obstructive Pulmonary Disease (COPD) according to definition of China COPD guideline. (


  • We studied the safety and feasibility of mild hypothermia in awake patients with stroke after intravenous thrombolysis. (

critically ill

  • Using these, the specific retrieval of sepsis symptoms or vital parameters, critically ill patients can be assessed at triage with higher reliability. (
  • Most of STAR Flight's hot-loaded patients were not critically ill or injured. (


  • However, adverse events (AEs) associated with these drugs, including the risk of extrapyramidal symptoms (e.g., dystonias, parkinsonism, and akathisia) and tardive dyskinesia at therapeutic doses limit their use in some patients. (


  • ICULIP,a Prospective,Multi-centre,Randomised,Comparative,Double-blind Study to Evaluate Two Different Types of Lipid Emulsions Used for Total Parenteral Nutrition in Critical Patients and Their Influence on Nosocomial Infection. (


  • Determine changes in lymphocyte subsets, immunoglobulin levels, serum cytokines, and soluble cytokine receptor levels in patients treated with this drug. (
  • The paradox of lean patients and fatty liver can be explained by high use of steroids, by rapid weight loss, and by the abundance of TNFα cytokine in IBD patients that causes insulin resistance. (


  • 1997). For patient entering Arm B (with N0 stage) confirmation of N1-N2 stage must be obtained from intraoperative or post-surgery pathology report. (


  • The incidence of compensatory sweating was reported spontaneously by patients during the postoperative evaluation (1 week, 1 month, 6 months and 12th month). (
  • The intensity of compensatory hyperhidrosis (CH) reported spontaneously by patients was graded as severe or non-severe. (


  • Determine the toxic effects of BL22 immunotoxin in pediatric patients with relapsed or refractory CD22-positive acute lymphoblastic leukemia or non-Hodgkin's lymphoma. (
  • Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. (


  • A community assessment to inform a multilevel intervention to reduce cardiovascular disease risk and. (


  • Patients of both sexes, prospective admission to Intensive Care Units (ICUs), over 18 years, where TPN is required as a nutritional metabolic support for a minimum period of 5 days and where said patients have signed the informed consent form. (


  • In this retrospective study of 20 836 randomly selected patients, 801 had sepsis on arrival at the ED. Using the MTS, 30% of patients with sepsis were erroneously categorised to low acuity priorities. (


  • Patients with severe sepsis were appropriately prioritised with a sensitivity of 84.5% (95% CI 78.1 to 89.4), and LR- was 0.330 (95% CI 0.243 to 0.450). (
  • 1 Internationally, it is assumed that approximately two-thirds of all patients with sepsis are admitted through the ED. 2 Data from the USA show a 0.7% prevalence for patients with severe sepsis for all ED cases, that is, 571 000 patients annually. (
  • Patients suffering from any other chronic severe diseases. (


  • Published On 9/2/2017 Relationship Between Laryngeal Sensory Deficits, Aspiration, and Pneumonia in Patients with Dysphagia. (


  • For patients entering Arm B is also allowed to confirm histopathological diagnosis of NSCLC intraoperatively during this trial. (


  • PURPOSE: This phase I trial is studying the side effects and best dose of BL22 immunotoxin in treating young patients with relapsed or refractory acute lymphoblastic leukemia or non-Hodgkin's lymphoma. (
  • Determine the in vitro cytotoxicity of this drug against lymphoblasts from patients with acute lymphoblastic leukemia. (


  • Each patient will undergo blood examinations in order to assess inflammation, and metabolic status. (


  • Once the MTD is determined, the cohort is expanded and a total of 12 patients are treated at that dose. (


  • Despite this fact, there are only few publications that evaluated the prevalence of fatty liver in IBD patients. (


  • Patients with clinically measurable lesions will be enrolled in this study. (
  • This study aims to analyse the effect of two total parenteral nutrition diets with lipid emulsions of different compositions on the incidence of nosocomial infection in critical patients. (
  • The purpose of this study is to see if there are any changes in sugar and fat levels in the blood when patients take anti-HIV therapy for many years. (
  • Factor analysis of the North American Spine Society outcome assessment instrument: a study based on a spine registry of patients treated with lumbar and cervical disc arthroplasty. (
  • The purpose of this study was to identify the frequency, ground time, and short-term outcomes of hot-loaded patients flown by the STAR Flight program. (


  • Cohorts of 3-6 patients receive escalating doses of BL22 immunotoxin until the maximum tolerated dose (MTD) is determined. (


  • 7 In a meta-analysis of experimental stroke, however, even mild hypothermia (35°C) improved outcome when initiated within 3 hours. (


  • Compare the incidence of nosocomial infection associated with the administration of two different lipid solutions in total parenteral nutrition of patients in an Intensive Care Unit. (


  • Results- We included 36 patients with a median of National Institutes of Health Stroke Scale score of 9 one hour after thrombolysis. (


  • Observation of these patients should provide more information about long-term anti-HIV treatment and may detect unexpected problems. (
  • Published On 9/19/2017 Age of first exposure to American football and long-term neuropsychiatric and cognitive outcomes. (


  • Mild to moderate hypothermia improves neurological outcome in resuscitated cardiac arrest patients and newborns with hypoxic brain damage. (


  • The mean age was 65 years, 67% of patients were male, and the median duration of T2DM at randomization was 11.9 years. (
  • Median Maximum Score for Patient Reported Outcomes in 2 Blinded Cycles [ Time Frame: Within the first 2 blinded cycles (3-week cycles), up to 6 weeks. (
  • Median maximum score (0 to 10, with 10 being the worst) for participant-reported outcomes in the first 2 blinded cycles for Mouth Pain, Overall Mouth and Throat Soreness, and Rectal Soreness while median maximum score for Swallowing, Drinking and Eating Difficulty (0 to 4, with 4 being the difficult). (



  • All participants were randomized into two groups of 20 patients (G3 and G4) and underwent the sympathectomy, being followed for 12 months. (
  • PATIENT SAMPLE: Three hundred ninety-one patients with low back pain and 553 patients with neck pain completed questionnaires preoperatively and again at 3 to 6 and 12 months follow-ups (FUs), in connection with the SWISSspine disc arthroplasty registry. (


  • It will also allow assessment of the levels of CD4 cell number at which vulnerability to opportunistic infection recur. (
  • Objective Evaluation of Patients With Palmar Hyperhidrosis Submitted to Two Levels of Sympathectomy: T3 and T4. (


  • To investigate the effects of genetic variation in mucositis genes, drug metabolism genes, and drug target genes on patient response to the treatment regimen. (
  • Determine the maximum tolerated dose of this drug in these patients. (
  • Hone an understanding of commonly prescribed medications for patients with mental health problems through Drug Profile boxes that complement text discussions of biologic processes associated with various mental health disorders. (


  • BACKGROUND CONTEXT: Studies involving factor analysis (FA) of the items in the North American Spine Society (NASS) outcome assessment instrument have revealed inconsistent factor structures for the individual items. (
  • The literature in adults is inconclusive and no studies have investigated the association between pacing leads and TR in children or congenital heart disease patients. (
  • Compelling case studies-supported by online videos that play out the scenarios in more depth-show students how to apply theory to specific patients, providing a seamless transition to the practice world. (
  • Develop a deeper understanding of mental health patients through case studies interwoven in the mental health disorder chapters that are brought to life by online videos of these case patients displaying these disorders. (


  • Improvements were also noted for the PSP, GAF, and total LOF, indicating improvement in daily functioning and health outcome. (


  • Results were analyzed by call nature, number of patients, and type of aircraft. (


  • Patients who met the criteria for sepsis were correctly prioritised with a sensitivity of 70.4% (95% CI 66.5 to 74.0). (


  • Background and Purpose- Hypothermia improves outcome in resuscitated patients and newborns with hypoxic brain injury. (


  • Patients were classified into one of three septic groups, or no sepsis. (


  • Patients in ACTG 362 have been exposed to anti-HIV therapy longer than any other large group in the ACTG. (
  • 1 - 4 In traumatic brain injury, 2 large controlled randomized trials recently found no improvement in outcome even with early-induced hypothermia. (

years old

  • IBD patients above the age of 18 years old, suffering from the disease for at least one year. (


  • First-generation or conventional oral antipsychotic agents, such as fluphenazine and haloperidol, have been used for decades to treat patients with schizophrenia and are effective in reducing many symptoms of the disease. (
  • AS PER AMENDMENT 11/16/99: The low rate of MAC in ACTG 362 patients after an average of 1 year of follow-up suggests that prophylaxis specifically for MAC disease with azithromycin is not necessary for patients who have experienced immune reconstitution. (
  • The detected change is minimal, suggesting that there is little impact of transvenous leads on TR, even in growing children or patients with right-sided structural heart disease. (


  • The hot-loaded patient: review and analysis of 1 year's experience. (


  • Patients who achieve a complete response (CR) or unconfirmed CR (CRu) receive 2 additional courses beyond CR or CRu for a maximum of 6 courses. (